AKB-9090

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameAKB-9090
Drug Alias NameAKB-9090
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsAcute Kidney InjuryRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAkebia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkebia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAcute Kidney InjuryRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A